High-Efficiency Genomic Integration Service utilizes advanced genome-editing platforms to achieve precise, stable, and high-yield transgene insertion, ensuring consistent expression and enhanced functionality of engineered immune cells.
Prolonged stimulation leads to functional exhaustion and decreased efficacy of the CAR-T cells. To address this issue, researchers have developed a synthetic cytokine receptor that can be incorporated into CAR-T cells to control their activation. A synthetic cytokine receptor is a genetically engineered protein that has been designed to mimic the function of natural cytokine receptors. It specifically recognizes and binds to an artificial ligand to precisely control the activation of CAR-T cells in a customizable and tunable manner.
A common design for a synthetic cytokine receptor contains the fusion of the extracellular domain of an artificial ligand, such as the VHHs, with the intracellular signaling domain of the cytokine receptor. Creative Biolabs offers synthetic cytokine receptor construction service, thus allowing for improvement of the safety and efficacy of CAR-T cell therapy. Our experts design synthetic cytokine receptor systems that can specifically respond to non-physiological ligands (such as fluorescent proteins) without interference from endogenous cytokines or other molecules in the biological system. This system is designed to eliminate false signals and provide a controllable and precise response to artificial ligands, allowing for more targeted and reliable cellular signaling. We utilize soluble VHHs as the ligand-binding domain to fine-tune the signaling pathways and cellular responses triggered upon ligand binding.
We offer comprehensive design and construction services for synthetic cytokine receptors.
Discover how we can help - Request a consultation.
How does this service compare to simply co-administering traditional cytokines like IL-2 or IL-15?
Co-administering bulk cytokines leads to systemic, non-specific immune activation, often causing severe toxicity. Our synthetic receptor approach localizes the signaling to the therapeutic T-cell population, providing the necessary persistence signals exclusively to the engineered cells, thus dramatically improving the therapeutic index and reducing systemic side effects.
Can your synthetic receptors be integrated into non-CAR cell therapies, such as TCR-T cells or NK cells?
Absolutely. Our receptor engineering platform is modular and designed to enhance the function of any adoptive cell therapy product. We view the synthetic receptor as a customizable "booster pack" for persistence and proliferation, regardless of the cell's primary targeting mechanism.
What precautions do you take regarding the potential for insertional mutagenesis or off-target effects during gene delivery?
We prioritize safety by using high-fidelity vector systems with characterized integration profiles. Furthermore, we can utilize advanced TRAC-CAR insertion techniques to ensure precise, site-specific gene insertion, minimizing the risk of random integration and maximizing the stability of the final product.
Initiate contact to schedule a confidential discussion and receive a comprehensive technical proposal.
High-Efficiency Genomic Integration Service utilizes advanced genome-editing platforms to achieve precise, stable, and high-yield transgene insertion, ensuring consistent expression and enhanced functionality of engineered immune cells.
Chimeric HLA Antibody Receptor (CHAR) Construction Service designs synthetic receptors that recognize HLA molecules, enabling selective immune modulation, tumor immune evasion targeting, and innovative approaches for personalized immunotherapy.
Creative Biolabs is dedicated to next-generation CAR-T cell development services. Our team of experts specializes in the development, optimization, and customization of synthetic receptors to meet the specific needs of our clients. We also transfer the gene of synthetic cytokine receptors into CAR-T cells and validate relevant biological functions. Our experienced team collaborates closely with our clients to understand their project requirements, optimize the design parameters, and deliver high-quality solutions that exceed expectations. If you are considering developing a synthetic cytokine receptor, please contact us to discuss your project requirements and explore how we assist you in constructing a synthetic cytokine receptor for your specific application.
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION